0102030405
CAS No 143900-44-1 (S) -1-Boc-3-Hydroxypiperidine Pharmaceutical Intermediates
02
introduce
S)-1-Boc-3-hydroxypiperidine is an important pharmaceutical intermediate. It is a piperidine derivative and has a chiral structure. It is widely used in pharmaceutical applications, particularly for the synthesis of ibrutinib, an anticancer drug targeting B-cell malignancies, as well as other pharmacological activities such as antibacterial, antitumor and treatment of Alzheimer's disease.
02
Physical and chemical properties
- Physical properties: The compound has a chiral structure and specific physical properties suitable for drug synthesis and drug development.
- Chemical properties: (S)-1-Boc-3-Hydroxypiperidine plays a key role in the synthesis of ibrutinib and exhibits multiple pharmacological activities, making it a valuable ingredient in the pharmaceutical industry.
Pharmaceutical Applications: This compound is widely used in the pharmaceutical industry, particularly for the synthesis of ibrutinib and other drugs used to treat various diseases, including lymphoma and viral infections.
- Research Support: (S)-1-Boc-3-Hydroxypiperidine provides researchers and pharmaceutical companies with a versatile tool for drug development, contributing to the advancement of medical science and the treatment of a variety of medical conditions.
- Quality Assurance: Our (S)-1-Boc-3-Hydroxypiperidine is produced under strict quality control measures to ensure purity and consistency, meeting the highest industry standards.
- Technical expertise: We provide comprehensive technical support and expertise to promote the effective utilization of (S)-1-Boc-3-hydroxypiperidine in drug research and development and promote industry innovation and progress.
In summary, (S)-1-Boc-3-Hydroxypiperidine is an important pharmaceutical intermediate with diverse applications in drug development and synthesis. With its chiral structure and diverse pharmacological activities, this compound plays a vital role in the pharmaceutical industry, helping to create essential drugs and therapeutic agents.